Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Chi

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
Cell Reports. Medicine|June 18, 2025
Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancerRun-Cong Nie, Xiao-Jiang Chen, Cheng-Cai Liang, et al.
Science (New York, N.Y.)|June 13, 2024
Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interactionYang Liu, Jing-Jing Jiang, Shao-Yue Du, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 10, 2003
[The epidemiology of neural tube defects in high-prevalence and low-prevalence areas of China]Li-jun Pei, Zhu Li, Song Li, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 16, 2025
Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation StudyJia-Yong Su, De-Jia Huang, Shao-Ping Liu, et al.
Signal Transduction and Targeted Therapy|February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trialRun-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 TrialRun-Cong Nie, Ying Jin, Cheng-Cai Liang, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
Cell Reports. Medicine|June 18, 2025
Safety and efficacy of perioperative dual PD-1 and HER2 blockade in HER2-positive gastric cancerRun-Cong Nie, Xiao-Jiang Chen, Cheng-Cai Liang, et al.
Science (New York, N.Y.)|June 13, 2024
Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interactionYang Liu, Jing-Jing Jiang, Shao-Yue Du, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|July 10, 2003
[The epidemiology of neural tube defects in high-prevalence and low-prevalence areas of China]Li-jun Pei, Zhu Li, Song Li, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 16, 2025
Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation StudyJia-Yong Su, De-Jia Huang, Shao-Ping Liu, et al.
Signal Transduction and Targeted Therapy|February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trialRun-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2026
Perioperative Toripalimab Plus Chemotherapy Versus Chemotherapy Alone in Locally Advanced Gastric or Gastroesophageal Junction Cancer: 3-Year Follow-Up of NEOSUMMIT-01 TrialRun-Cong Nie, Ying Jin, Cheng-Cai Liang, et al.
Pageof 18